RomReal Limited (OSL:ROM)
Norway · Delayed Price · Currency is NOK 2.700
0.00 (0.00%)
At close: Apr 1, 2026
RomReal Revenue
In the year 2025, RomReal had annual revenue of 2.30M EUR with 199.47% growth. RomReal had revenue of 438.00K in the quarter ending December 31, 2025.
Revenue
2.30M EUR
Revenue Growth
+199.47%
P/S Ratio
4.00
Revenue / Employee
209.36K EUR
Employees
11
Market Cap
108.91M NOK
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.30M | 1.53M | 199.47% |
| Dec 31, 2024 | 769.04K | 197.48K | 34.55% |
| Dec 31, 2023 | 571.56K | -4.28M | -88.22% |
| Dec 31, 2022 | 4.85M | 1.14M | 30.77% |
| Dec 31, 2021 | 3.71M | 2.07M | 126.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| REC Silicon ASA | 788.31M |
| Høland og Setskog Sparebank | 162.85M |
| Interoil Exploration and Production ASA | 159.53M |
| Nidaros Sparebank | 143.29M |
| Barramundi Group | 109.55M |
| Aqua Bio Technology ASA | 101.51M |
| Arctic Bioscience AS | 45.90M |
| Norwegian Block Exchange AS | 16.25M |